- Fresenius saw adjusted net income rise 24% in Q1 due to new generic drugs and supply issues at rivals. Fresenius Medical Care confirmed 15-20% net income growth target for the year after Q1 net income rose 9%. - Grifols' Q1 net revenues increased 5.6% to $1.1 billion, with recurring sales up 7.1%. Novo Nordisk plans to meet all of Russia's insulin demand in coming years. - Sanofi said it will try to replace Medivation's board if it does not engage in takeover talks. Smith & Nephew reported 3% revenue growth in Q1 and backed full-year guidance.